Share Price and Basic Stock Data
Last Updated: December 19, 2025, 4:40 am
| PEG Ratio | 3.33 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Coromandel International Ltd operates in the fertiliser sector, a crucial industry for India’s agricultural backbone. The company’s recent financials indicate a robust performance trajectory, with reported sales of ₹29,628 Cr in FY 2023, a significant increase from ₹19,111 Cr in FY 2022. This upward trend reflects the growing demand for fertilisers, driven by the agricultural sector’s resilience and the government’s focus on enhancing food production. However, the sales dipped to ₹22,058 Cr in FY 2024 before rebounding to ₹24,085 Cr in FY 2025, indicating some volatility. Quarterly sales figures also suggest fluctuations, with a peak of ₹10,113 Cr in September 2022, followed by more stable numbers in recent quarters. This underscores the cyclical nature of the fertiliser market, influenced by seasonal agricultural demands and pricing dynamics.
Profitability and Efficiency Metrics
Coromandel’s profitability metrics present a mixed picture but largely reflect healthy operational efficiency. The operating profit margin (OPM) stood at 11% for FY 2025, maintaining a stable range between 10% and 12% over the past few years. This consistency suggests effective cost management amidst fluctuating raw material prices. The net profit for FY 2025 was reported at ₹2,055 Cr, with a net profit margin of 8.75%, indicating a reasonable return on sales. Moreover, the company boasts a return on equity (ROE) of 16.9% and a return on capital employed (ROCE) of 23.2%, both of which appear strong relative to industry norms. However, the interest coverage ratio (ICR) of 11.38x suggests that while the company can comfortably meet its interest obligations, the rising interest rates pose a risk to future profitability.
Balance Sheet Strength and Financial Ratios
Coromandel’s balance sheet exhibits strength, with total borrowings recorded at ₹780 Cr against reserves of ₹11,058 Cr. This low leverage indicates a conservative financial strategy, which is beneficial in times of economic uncertainty. The company’s current ratio of 1.89x suggests good short-term financial health, enabling it to cover its short-term liabilities comfortably. Furthermore, with a price-to-book value ratio of 5.26x, the stock appears to be trading at a premium, reflecting investor confidence in its growth potential. However, the enterprise value (EV) to EBITDA ratio of 18.47x indicates that the stock may be perceived as somewhat overvalued compared to its earnings potential, which could deter some value-focused investors. Overall, the balance sheet’s strength juxtaposed with elevated valuation metrics presents a nuanced picture.
Shareholding Pattern and Investor Confidence
Coromandel’s shareholding pattern offers insights into investor sentiment and confidence. The promoter holding stands at a stable 56.88%, providing a strong foundation for governance. Notably, foreign institutional investors (FIIs) have increased their stake to 14.45%, up from a low of 7.56% in June 2023, signalling growing international interest. Domestic institutional investors (DIIs) hold a solid 15.88%, reflecting confidence from local funds. The public shareholding, however, has gradually decreased to 12.70%, which could suggest a consolidation of ownership among larger stakeholders. This shift may indicate that retail investors are cautious amid market volatility. Such a concentrated ownership structure could lead to significant price movements in case of any strategic changes or market reactions.
Outlook, Risks, and Final Insight
Looking ahead, Coromandel International Ltd faces a landscape filled with both opportunities and challenges. The company’s strong fundamentals, backed by solid profitability and a conservative balance sheet, position it well for growth in the fertiliser sector. However, risks such as fluctuating commodity prices, regulatory changes, and potential disruptions in supply chains could impact its performance. Investors might consider the cyclical nature of the fertiliser market, which can lead to unpredictable earnings. Additionally, the high valuation metrics may deter some investors, especially those looking for value plays. Overall, while Coromandel presents an appealing investment case rooted in its operational strengths, potential investors should remain vigilant about market dynamics and external factors that could influence future performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat State Fertilizers & Chemicals Ltd | 6,755 Cr. | 170 | 221/156 | 10.1 | 313 | 2.95 % | 6.18 % | 4.77 % | 2.00 |
| Bharat Agri Fert & Realty Ltd | 162 Cr. | 30.6 | 75.9/29.0 | 9.97 | 0.00 % | 6.14 % | 14.8 % | 1.00 | |
| Basant Agro Tech (India) Ltd | 102 Cr. | 11.3 | 19.6/10.9 | 20.3 | 20.0 | 0.44 % | 6.52 % | 2.36 % | 1.00 |
| Zuari Agro Chemicals Ltd | 1,302 Cr. | 311 | 395/155 | 3.77 | 602 | 0.00 % | 12.7 % | 9.06 % | 10.0 |
| Southern Petrochemicals Industries Corporation Ltd (SPIC) | 1,596 Cr. | 78.4 | 128/66.2 | 8.59 | 63.8 | 2.55 % | 16.9 % | 13.8 % | 10.0 |
| Industry Average | 10,492.33 Cr | 388.16 | 48.52 | 185.72 | 0.99% | 13.03% | 10.58% | 6.96 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,729 | 10,113 | 8,310 | 5,476 | 5,693 | 6,988 | 5,464 | 3,913 | 4,729 | 7,433 | 6,935 | 4,988 | 7,042 |
| Expenses | 5,044 | 9,056 | 7,539 | 5,089 | 4,988 | 5,933 | 5,115 | 3,650 | 4,238 | 6,471 | 6,222 | 4,579 | 6,260 |
| Operating Profit | 685 | 1,057 | 771 | 387 | 706 | 1,055 | 349 | 263 | 490 | 962 | 713 | 409 | 782 |
| OPM % | 12% | 10% | 9% | 7% | 12% | 15% | 6% | 7% | 10% | 13% | 10% | 8% | 11% |
| Other Income | 55 | 32 | 40 | 47 | 44 | 45 | 59 | 84 | 54 | 65 | 114 | 473 | 84 |
| Interest | 27 | 54 | 57 | 52 | 41 | 46 | 38 | 62 | 57 | 66 | 73 | 66 | 68 |
| Depreciation | 45 | 46 | 47 | 45 | 48 | 54 | 64 | 63 | 65 | 69 | 71 | 85 | 121 |
| Profit before tax | 669 | 989 | 706 | 337 | 661 | 1,000 | 306 | 222 | 422 | 892 | 683 | 731 | 677 |
| Tax % | 25% | 25% | 25% | 27% | 25% | 25% | 25% | 26% | 27% | 26% | 26% | 21% | 26% |
| Net Profit | 499 | 741 | 527 | 246 | 494 | 755 | 228 | 164 | 309 | 659 | 508 | 578 | 502 |
| EPS in Rs | 16.99 | 25.20 | 17.92 | 8.38 | 16.80 | 25.71 | 7.85 | 5.45 | 10.56 | 22.55 | 17.37 | 19.67 | 17.13 |
Last Updated: August 1, 2025, 10:30 pm
Below is a detailed analysis of the quarterly data for Coromandel International Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 7,042.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,988.00 Cr. (Mar 2025) to 7,042.00 Cr., marking an increase of 2,054.00 Cr..
- For Expenses, as of Jun 2025, the value is 6,260.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,579.00 Cr. (Mar 2025) to 6,260.00 Cr., marking an increase of 1,681.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 782.00 Cr.. The value appears strong and on an upward trend. It has increased from 409.00 Cr. (Mar 2025) to 782.00 Cr., marking an increase of 373.00 Cr..
- For OPM %, as of Jun 2025, the value is 11.00%. The value appears strong and on an upward trend. It has increased from 8.00% (Mar 2025) to 11.00%, marking an increase of 3.00%.
- For Other Income, as of Jun 2025, the value is 84.00 Cr.. The value appears to be declining and may need further review. It has decreased from 473.00 Cr. (Mar 2025) to 84.00 Cr., marking a decrease of 389.00 Cr..
- For Interest, as of Jun 2025, the value is 68.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 66.00 Cr. (Mar 2025) to 68.00 Cr., marking an increase of 2.00 Cr..
- For Depreciation, as of Jun 2025, the value is 121.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 85.00 Cr. (Mar 2025) to 121.00 Cr., marking an increase of 36.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 677.00 Cr.. The value appears to be declining and may need further review. It has decreased from 731.00 Cr. (Mar 2025) to 677.00 Cr., marking a decrease of 54.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 21.00% (Mar 2025) to 26.00%, marking an increase of 5.00%.
- For Net Profit, as of Jun 2025, the value is 502.00 Cr.. The value appears to be declining and may need further review. It has decreased from 578.00 Cr. (Mar 2025) to 502.00 Cr., marking a decrease of 76.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 17.13. The value appears to be declining and may need further review. It has decreased from 19.67 (Mar 2025) to 17.13, marking a decrease of 2.54.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:29 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10,053 | 11,306 | 11,481 | 10,031 | 11,083 | 13,225 | 13,137 | 14,182 | 19,111 | 29,628 | 22,058 | 24,085 | 28,620 |
| Expenses | 9,246 | 10,450 | 10,712 | 9,048 | 9,822 | 11,775 | 11,400 | 12,193 | 16,954 | 26,726 | 19,678 | 21,508 | 25,569 |
| Operating Profit | 808 | 856 | 769 | 983 | 1,261 | 1,450 | 1,737 | 1,989 | 2,156 | 2,902 | 2,380 | 2,577 | 3,051 |
| OPM % | 8% | 8% | 7% | 10% | 11% | 11% | 13% | 14% | 11% | 10% | 11% | 11% | 11% |
| Other Income | 46 | 50 | 87 | 54 | 55 | 8 | 35 | 76 | 141 | 171 | 223 | 703 | 787 |
| Interest | 240 | 210 | 221 | 224 | 178 | 251 | 235 | 106 | 75 | 190 | 187 | 262 | 309 |
| Depreciation | 96 | 105 | 106 | 101 | 99 | 114 | 158 | 173 | 173 | 182 | 229 | 290 | 378 |
| Profit before tax | 517 | 592 | 529 | 712 | 1,038 | 1,093 | 1,379 | 1,786 | 2,050 | 2,701 | 2,188 | 2,728 | 3,151 |
| Tax % | 29% | 32% | 32% | 33% | 33% | 34% | 23% | 26% | 25% | 25% | 25% | 25% | |
| Net Profit | 365 | 402 | 357 | 477 | 691 | 720 | 1,065 | 1,329 | 1,528 | 2,013 | 1,641 | 2,055 | 2,381 |
| EPS in Rs | 12.59 | 13.80 | 12.27 | 16.35 | 23.64 | 24.63 | 36.36 | 45.30 | 52.08 | 68.46 | 55.78 | 70.14 | 81.48 |
| Dividend Payout % | 36% | 33% | 33% | 31% | 27% | 26% | 33% | 26% | 23% | 18% | 11% | 21% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 10.14% | -11.19% | 33.61% | 44.86% | 4.20% | 47.92% | 24.79% | 14.97% | 31.74% | -18.48% | 25.23% |
| Change in YoY Net Profit Growth (%) | 0.00% | -21.33% | 44.81% | 11.25% | -40.67% | 43.72% | -23.13% | -9.82% | 16.77% | -50.22% | 43.71% |
Coromandel International Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 13% |
| 3 Years: | 8% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 10% |
| 3 Years: | 4% |
| TTM: | 36% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 25% |
| 3 Years: | 31% |
| 1 Year: | 33% |
| Return on Equity | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 23% |
| 3 Years: | 21% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 2:15 am
Balance Sheet
Last Updated: December 10, 2025, 2:33 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 28 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 |
| Reserves | 2,253 | 2,173 | 2,605 | 2,862 | 2,867 | 3,329 | 4,288 | 5,121 | 6,329 | 7,878 | 9,390 | 11,058 | 12,149 |
| Borrowings | 1,843 | 2,288 | 2,677 | 2,228 | 2,728 | 2,954 | 2,019 | 385 | 395 | 393 | 492 | 780 | 1,471 |
| Other Liabilities | 3,481 | 3,872 | 3,871 | 3,526 | 4,224 | 4,261 | 3,812 | 3,360 | 4,532 | 5,934 | 5,933 | 7,049 | 11,086 |
| Total Liabilities | 7,605 | 8,362 | 9,182 | 8,645 | 9,848 | 10,574 | 10,149 | 8,895 | 11,285 | 14,235 | 15,845 | 18,917 | 24,736 |
| Fixed Assets | 1,734 | 1,380 | 1,320 | 1,328 | 1,327 | 1,309 | 2,032 | 2,015 | 2,092 | 2,200 | 3,112 | 4,139 | 5,574 |
| CWIP | 74 | 46 | 42 | 22 | 48 | 191 | 65 | 90 | 141 | 399 | 235 | 396 | 938 |
| Investments | 342 | 352 | 477 | 388 | 221 | 201 | 211 | 214 | 243 | 287 | 854 | 1,031 | 3,079 |
| Other Assets | 5,455 | 6,583 | 7,343 | 6,907 | 8,252 | 8,873 | 7,840 | 6,576 | 8,809 | 11,348 | 11,644 | 13,351 | 15,144 |
| Total Assets | 7,605 | 8,362 | 9,182 | 8,645 | 9,848 | 10,574 | 10,149 | 8,895 | 11,285 | 14,235 | 15,845 | 18,917 | 24,736 |
Below is a detailed analysis of the balance sheet data for Coromandel International Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 29.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 29.00 Cr..
- For Reserves, as of Sep 2025, the value is 12,149.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,058.00 Cr. (Mar 2025) to 12,149.00 Cr., marking an increase of 1,091.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,471.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 780.00 Cr. (Mar 2025) to 1,471.00 Cr., marking an increase of 691.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 11,086.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,049.00 Cr. (Mar 2025) to 11,086.00 Cr., marking an increase of 4,037.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 24,736.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18,917.00 Cr. (Mar 2025) to 24,736.00 Cr., marking an increase of 5,819.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 5,574.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,139.00 Cr. (Mar 2025) to 5,574.00 Cr., marking an increase of 1,435.00 Cr..
- For CWIP, as of Sep 2025, the value is 938.00 Cr.. The value appears strong and on an upward trend. It has increased from 396.00 Cr. (Mar 2025) to 938.00 Cr., marking an increase of 542.00 Cr..
- For Investments, as of Sep 2025, the value is 3,079.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,031.00 Cr. (Mar 2025) to 3,079.00 Cr., marking an increase of 2,048.00 Cr..
- For Other Assets, as of Sep 2025, the value is 15,144.00 Cr.. The value appears strong and on an upward trend. It has increased from 13,351.00 Cr. (Mar 2025) to 15,144.00 Cr., marking an increase of 1,793.00 Cr..
- For Total Assets, as of Sep 2025, the value is 24,736.00 Cr.. The value appears strong and on an upward trend. It has increased from 18,917.00 Cr. (Mar 2025) to 24,736.00 Cr., marking an increase of 5,819.00 Cr..
Notably, the Reserves (12,149.00 Cr.) exceed the Borrowings (1,471.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 807.00 | 854.00 | 767.00 | 981.00 | -1.00 | -1.00 | -1.00 | -384.00 | -393.00 | -391.00 | -490.00 | -778.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54 | 47 | 52 | 59 | 52 | 50 | 48 | 14 | 5 | 7 | 23 | 19 |
| Inventory Days | 86 | 96 | 98 | 88 | 109 | 127 | 109 | 98 | 94 | 69 | 102 | 98 |
| Days Payable | 132 | 131 | 135 | 150 | 162 | 147 | 135 | 110 | 100 | 83 | 117 | 123 |
| Cash Conversion Cycle | 7 | 12 | 15 | -3 | -2 | 30 | 22 | 2 | -1 | -7 | 8 | -7 |
| Working Capital Days | 4 | 11 | 24 | 40 | 27 | 42 | 65 | 64 | 41 | 37 | 44 | 28 |
| ROCE % | 16% | 19% | 15% | 18% | 23% | 23% | 26% | 32% | 35% | 38% | 26% | 23% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Kotak Midcap Fund | 5,728,809 | 2.26 | 1364.66 | N/A | N/A | N/A |
| HDFC Mid Cap Fund | 4,413,689 | 1.14 | 1051.38 | 4,272,186 | 2025-12-15 00:12:55 | 3.31% |
| Kotak Large & Midcap Fund | 3,250,001 | 2.58 | 774.18 | N/A | N/A | N/A |
| Axis Midcap Fund | 2,692,866 | 1.99 | 641.47 | 4,652,378 | 2025-12-08 05:46:03 | -42.12% |
| DSP Mid Cap Fund | 2,282,965 | 2.74 | 543.83 | 5,065,035 | 2025-12-08 05:46:03 | -54.93% |
| Sundaram Mid Cap Fund | 1,731,201 | 3.09 | 412.39 | 1,712,601 | 2025-12-15 00:12:55 | 1.09% |
| Kotak Flexicap Fund | 1,500,000 | 0.63 | 357.32 | N/A | N/A | N/A |
| Nippon India Growth Mid Cap Fund | 1,210,830 | 0.69 | 288.43 | N/A | N/A | N/A |
| HSBC Value Fund | 972,513 | 1.59 | 231.66 | N/A | N/A | N/A |
| PGIM India Midcap Fund | 872,543 | 1.8 | 207.85 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 70.23 | 55.81 | 68.51 | 52.09 | 45.34 |
| Diluted EPS (Rs.) | 70.12 | 55.81 | 68.38 | 51.98 | 45.22 |
| Cash EPS (Rs.) | 81.42 | 64.39 | 75.49 | 57.83 | 51.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 376.37 | 320.88 | 268.97 | 216.64 | 175.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 376.37 | 320.88 | 268.97 | 216.64 | 175.55 |
| Revenue From Operations / Share (Rs.) | 817.56 | 749.27 | 1007.75 | 651.14 | 483.37 |
| PBDIT / Share (Rs.) | 101.39 | 89.34 | 105.35 | 78.16 | 70.19 |
| PBIT / Share (Rs.) | 91.54 | 81.57 | 99.16 | 72.28 | 64.29 |
| PBT / Share (Rs.) | 94.40 | 75.24 | 92.70 | 69.71 | 60.69 |
| Net Profit / Share (Rs.) | 71.56 | 56.63 | 69.30 | 51.95 | 45.12 |
| NP After MI And SOA / Share (Rs.) | 70.14 | 55.78 | 68.47 | 52.08 | 45.30 |
| PBDIT Margin (%) | 12.40 | 11.92 | 10.45 | 12.00 | 14.52 |
| PBIT Margin (%) | 11.19 | 10.88 | 9.83 | 11.10 | 13.30 |
| PBT Margin (%) | 11.54 | 10.04 | 9.19 | 10.70 | 12.55 |
| Net Profit Margin (%) | 8.75 | 7.55 | 6.87 | 7.97 | 9.33 |
| NP After MI And SOA Margin (%) | 8.57 | 7.44 | 6.79 | 7.99 | 9.37 |
| Return on Networth / Equity (%) | 18.63 | 17.43 | 25.45 | 24.03 | 25.80 |
| Return on Capital Employeed (%) | 22.59 | 24.04 | 34.79 | 31.11 | 33.71 |
| Return On Assets (%) | 10.91 | 10.35 | 14.14 | 13.54 | 14.94 |
| Long Term Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 1.39 | 1.47 | 2.32 | 1.90 | 1.48 |
| Current Ratio (X) | 1.89 | 2.07 | 1.75 | 1.87 | 1.98 |
| Quick Ratio (X) | 1.21 | 1.28 | 0.99 | 1.05 | 1.19 |
| Inventory Turnover Ratio (X) | 2.75 | 3.00 | 4.84 | 3.80 | 2.65 |
| Dividend Payout Ratio (NP) (%) | 17.08 | 10.75 | 17.51 | 23.03 | 39.70 |
| Dividend Payout Ratio (CP) (%) | 14.98 | 9.44 | 16.06 | 20.70 | 35.12 |
| Earning Retention Ratio (%) | 82.92 | 89.25 | 82.49 | 76.97 | 60.30 |
| Cash Earning Retention Ratio (%) | 85.02 | 90.56 | 83.94 | 79.30 | 64.88 |
| Interest Coverage Ratio (X) | 11.38 | 14.10 | 16.30 | 30.40 | 19.49 |
| Interest Coverage Ratio (Post Tax) (X) | 7.71 | 9.94 | 11.72 | 21.20 | 13.53 |
| Enterprise Value (Cr.) | 55161.09 | 28896.11 | 24436.79 | 21701.81 | 21993.08 |
| EV / Net Operating Revenue (X) | 2.29 | 1.31 | 0.82 | 1.14 | 1.55 |
| EV / EBITDA (X) | 18.47 | 10.99 | 7.89 | 9.46 | 10.68 |
| MarketCap / Net Operating Revenue (X) | 2.42 | 1.44 | 0.87 | 1.23 | 1.60 |
| Retention Ratios (%) | 82.91 | 89.24 | 82.48 | 76.96 | 60.29 |
| Price / BV (X) | 5.26 | 3.36 | 3.27 | 3.69 | 4.41 |
| Price / Net Operating Revenue (X) | 2.42 | 1.44 | 0.87 | 1.23 | 1.60 |
| EarningsYield | 0.03 | 0.05 | 0.07 | 0.06 | 0.05 |
After reviewing the key financial ratios for Coromandel International Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 70.23. This value is within the healthy range. It has increased from 55.81 (Mar 24) to 70.23, marking an increase of 14.42.
- For Diluted EPS (Rs.), as of Mar 25, the value is 70.12. This value is within the healthy range. It has increased from 55.81 (Mar 24) to 70.12, marking an increase of 14.31.
- For Cash EPS (Rs.), as of Mar 25, the value is 81.42. This value is within the healthy range. It has increased from 64.39 (Mar 24) to 81.42, marking an increase of 17.03.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 376.37. It has increased from 320.88 (Mar 24) to 376.37, marking an increase of 55.49.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 376.37. It has increased from 320.88 (Mar 24) to 376.37, marking an increase of 55.49.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 817.56. It has increased from 749.27 (Mar 24) to 817.56, marking an increase of 68.29.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 101.39. This value is within the healthy range. It has increased from 89.34 (Mar 24) to 101.39, marking an increase of 12.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is 91.54. This value is within the healthy range. It has increased from 81.57 (Mar 24) to 91.54, marking an increase of 9.97.
- For PBT / Share (Rs.), as of Mar 25, the value is 94.40. This value is within the healthy range. It has increased from 75.24 (Mar 24) to 94.40, marking an increase of 19.16.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 71.56. This value is within the healthy range. It has increased from 56.63 (Mar 24) to 71.56, marking an increase of 14.93.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 70.14. This value is within the healthy range. It has increased from 55.78 (Mar 24) to 70.14, marking an increase of 14.36.
- For PBDIT Margin (%), as of Mar 25, the value is 12.40. This value is within the healthy range. It has increased from 11.92 (Mar 24) to 12.40, marking an increase of 0.48.
- For PBIT Margin (%), as of Mar 25, the value is 11.19. This value is within the healthy range. It has increased from 10.88 (Mar 24) to 11.19, marking an increase of 0.31.
- For PBT Margin (%), as of Mar 25, the value is 11.54. This value is within the healthy range. It has increased from 10.04 (Mar 24) to 11.54, marking an increase of 1.50.
- For Net Profit Margin (%), as of Mar 25, the value is 8.75. This value is within the healthy range. It has increased from 7.55 (Mar 24) to 8.75, marking an increase of 1.20.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.57. This value is within the healthy range. It has increased from 7.44 (Mar 24) to 8.57, marking an increase of 1.13.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.63. This value is within the healthy range. It has increased from 17.43 (Mar 24) to 18.63, marking an increase of 1.20.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.59. This value is within the healthy range. It has decreased from 24.04 (Mar 24) to 22.59, marking a decrease of 1.45.
- For Return On Assets (%), as of Mar 25, the value is 10.91. This value is within the healthy range. It has increased from 10.35 (Mar 24) to 10.91, marking an increase of 0.56.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.39. It has decreased from 1.47 (Mar 24) to 1.39, marking a decrease of 0.08.
- For Current Ratio (X), as of Mar 25, the value is 1.89. This value is within the healthy range. It has decreased from 2.07 (Mar 24) to 1.89, marking a decrease of 0.18.
- For Quick Ratio (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.28 (Mar 24) to 1.21, marking a decrease of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.75. This value is below the healthy minimum of 4. It has decreased from 3.00 (Mar 24) to 2.75, marking a decrease of 0.25.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 17.08. This value is below the healthy minimum of 20. It has increased from 10.75 (Mar 24) to 17.08, marking an increase of 6.33.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 14.98. This value is below the healthy minimum of 20. It has increased from 9.44 (Mar 24) to 14.98, marking an increase of 5.54.
- For Earning Retention Ratio (%), as of Mar 25, the value is 82.92. This value exceeds the healthy maximum of 70. It has decreased from 89.25 (Mar 24) to 82.92, marking a decrease of 6.33.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 85.02. This value exceeds the healthy maximum of 70. It has decreased from 90.56 (Mar 24) to 85.02, marking a decrease of 5.54.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 11.38. This value is within the healthy range. It has decreased from 14.10 (Mar 24) to 11.38, marking a decrease of 2.72.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 7.71. This value is within the healthy range. It has decreased from 9.94 (Mar 24) to 7.71, marking a decrease of 2.23.
- For Enterprise Value (Cr.), as of Mar 25, the value is 55,161.09. It has increased from 28,896.11 (Mar 24) to 55,161.09, marking an increase of 26,264.98.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.29. This value is within the healthy range. It has increased from 1.31 (Mar 24) to 2.29, marking an increase of 0.98.
- For EV / EBITDA (X), as of Mar 25, the value is 18.47. This value exceeds the healthy maximum of 15. It has increased from 10.99 (Mar 24) to 18.47, marking an increase of 7.48.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.42. This value is within the healthy range. It has increased from 1.44 (Mar 24) to 2.42, marking an increase of 0.98.
- For Retention Ratios (%), as of Mar 25, the value is 82.91. This value exceeds the healthy maximum of 70. It has decreased from 89.24 (Mar 24) to 82.91, marking a decrease of 6.33.
- For Price / BV (X), as of Mar 25, the value is 5.26. This value exceeds the healthy maximum of 3. It has increased from 3.36 (Mar 24) to 5.26, marking an increase of 1.90.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.42. This value is within the healthy range. It has increased from 1.44 (Mar 24) to 2.42, marking an increase of 0.98.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 24) to 0.03, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Coromandel International Ltd:
- Net Profit Margin: 8.75%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.59% (Industry Average ROCE: 13.03%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.63% (Industry Average ROE: 10.58%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 7.71
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.21
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 31.2 (Industry average Stock P/E: 48.52)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.75%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Fertilisers | Coromandel House, Secunderabad Telangana 500003 | investorsgrievance@coromandel.murugappa.com http://www.coromandel.biz |
| Management | |
|---|---|
| Name | Position Held |
| Mr. A Vellayan | Chairman Emeritus |
| Mr. Arun Alagappan | Executive Chairman |
| Mr. Natrajan Srinivasan | Executive Vice Chairman |
| Mr. S Sankarasubramanian | Managing Director & CEO |
| Dr. Raghuram Devarakonda | Executive Director |
| Mr. Arunachalam Vellayan | Whole Time Director |
| Mr. Narayanan Vellayan | Whole Time Director |
| Mr. Sudarshan Venu | Independent Director |
| Dr. Deepali Pant Joshi | Independent Director |
| Mr. Adnan Ahmad | Independent Director |
| Mr. Aditya Himatsingka | Independent Director |
| Mr. Suresh Subramanian | Independent Director |
| Mr. Durgashankar Subramaniam | Independent Director |
FAQ
What is the intrinsic value of Coromandel International Ltd?
Coromandel International Ltd's intrinsic value (as of 19 December 2025) is 1751.37 which is 22.09% lower the current market price of 2,248.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 66,312 Cr. market cap, FY2025-2026 high/low of 2,720/1,590, reserves of ₹12,149 Cr, and liabilities of 24,736 Cr.
What is the Market Cap of Coromandel International Ltd?
The Market Cap of Coromandel International Ltd is 66,312 Cr..
What is the current Stock Price of Coromandel International Ltd as on 19 December 2025?
The current stock price of Coromandel International Ltd as on 19 December 2025 is 2,248.
What is the High / Low of Coromandel International Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Coromandel International Ltd stocks is 2,720/1,590.
What is the Stock P/E of Coromandel International Ltd?
The Stock P/E of Coromandel International Ltd is 31.2.
What is the Book Value of Coromandel International Ltd?
The Book Value of Coromandel International Ltd is 413.
What is the Dividend Yield of Coromandel International Ltd?
The Dividend Yield of Coromandel International Ltd is 0.53 %.
What is the ROCE of Coromandel International Ltd?
The ROCE of Coromandel International Ltd is 23.2 %.
What is the ROE of Coromandel International Ltd?
The ROE of Coromandel International Ltd is 16.9 %.
What is the Face Value of Coromandel International Ltd?
The Face Value of Coromandel International Ltd is 1.00.